Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

Role of Locoregional Treatment after Good Response to Systemic Chemotherapy in Metastatic Nasopharyngeal Cancer : A Case Report

원격 전이가 동반된 비인두암에서 항암화학요법 후 치료 반응을 보인 환자에 대한 국소치료의 역할 : 증례보고

  • Lee, Joo Ho (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Wu, Hong-Gyun (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Heo, Dae Seog (Department of Internal Medicine, Seoul National University College of Medicine)
  • 이주호 (서울대학교 의과대학 방사선종양학교실) ;
  • 우홍균 (서울대학교 의과대학 방사선종양학교실) ;
  • 허대석 (서울대학교 의과대학 내과학교실)
  • Received : 2013.09.18
  • Accepted : 2013.11.05
  • Published : 2013.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

원격 전이된 비인두암 환자에서 주요한 치료 방법은 고식적 항암화학치료에 국한되어왔다. 그러나 적극적인 항암화학치료로 비인두암 환자 중 많은 환자에서 치료 반응을 보이며, 치료 반응을 보인 환자군에서는 국소 제어가 중요한 문제가 된다. 본 저자들은 원격 전이 된 환자 1예를 보고하고자 한다. 환자는 큰 크기의 다발성 전이가 있었으나 항암화학요법으로 관해 상태를 보였다. 이후 공고화 항암화학방사선요법을 추가하였고 현재 30개월 간 무병상태이다. 원격전이된 비인두암에서 공고화 항암화학방사선 요법의 역할에 대하여 문헌 고찰을 통해 논의하고자 한다.

Keywords

References

  1. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261-270. https://doi.org/10.1016/0360-3016(92)90740-9
  2. Loong HH, Ma BB, Chan AT. Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer. Hematol Oncol Clin North Am. 2008;22:1267-1278, x. https://doi.org/10.1016/j.hoc.2008.08.012
  3. Ji JH, Yun T, Kim SB, Kang JH, Park JC, Cho IS, et al. A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer(KCSG HN07-01). Eur J Cancer. 2012;48:3198-204. https://doi.org/10.1016/j.ejca.2012.06.009
  4. Song CH, Wu HG, Heo DS, Kim KH, Sung MW, Park CI. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma. Laryngoscope. 2008;118:663-670. https://doi.org/10.1097/MLG.0b013e3181626cfe
  5. Lin H, Cai X, Jin T, Guo L, Wang H, Sun R, et al. Chemotherapy plus radiotherapy makes curability a possibility in nasopharyngeal carcinoma patients with distant metastasis at diagnosis. Head Neck Oncol. 2013;5:1.
  6. Lin S, Tham IW, Pan J, Han L, Chen Q, Lu JJ. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer. Am J Clin Oncol. 2012;35:474-479. https://doi.org/10.1097/COC.0b013e31821a9452
  7. Fandi A, Bachouchi M, Azli N, Taamma A, Boussen H, Wibault P, et al. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol. 2000;18:1324-1330. https://doi.org/10.1200/JCO.2000.18.6.1324
  8. Kong L, Hu C, Niu X, Zhang Y, Guo Y, Tham IW, et al. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: Interim results from 2 prospective phase 2 clinical trials. Cancer. In press 2013.
  9. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007; 357:1705-1715. https://doi.org/10.1056/NEJMoa070956
  10. Schrijvers D, Van Herpen C, Kerger J, Joosens E, Van Laer C, Awada A, et al. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: A phase I-II feasibility study. Ann Oncol. 2004;15:638-45. https://doi.org/10.1093/annonc/mdh145
  11. Jeremic B, Shibamoto Y, Nikolic N, Milicic B, Milisavljevic S, Dagovic A, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study. J Clin Oncol. 1999;17:2092-2099. https://doi.org/10.1200/JCO.1999.17.7.2092
  12. Laskar S, Gupta T, Vimal S, Muckaden MA, Saikia TK, Pai SK, et al. Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: Is there a need? J Clin Oncol. 2004;22:62-68. https://doi.org/10.1200/JCO.2004.01.021
  13. Kretschmar C, Kleinberg L, Greenberg M, Burger P, Holmes E, Wharam M. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2007;48:285-291. https://doi.org/10.1002/pbc.20815
  14. Patil V, Noronha V, Joshi A, Muddu Krishna V, Juvekar S, Pantvaidya G, et al. Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy? ISRN Oncol. 2013;2013:259154.
  15. Fang WJ, Lam KO, Ng SC, Choi CW, Kwong DL, Zheng SS, et al. Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: A comparison with RECIST. Asian Pac J Cancer Prev. 2013;14:4151-4155. https://doi.org/10.7314/APJCP.2013.14.7.4151